Copyright Reports & Markets. All rights reserved.

Global Premature Ejaculation Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Premature Ejaculation Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Premature Ejaculation Treatment Market Size Growth Rate by Product
      • 1.4.2 Cialis
      • 1.4.3 Viagra
      • 1.4.4 Levitra
    • 1.5 Market by End User
      • 1.5.1 Global Premature Ejaculation Treatment Market Size Growth Rate by End User
      • 1.5.2 Supermarket
      • 1.5.3 Hospital
      • 1.5.4 Pharmacy
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Premature Ejaculation Treatment Market Size
      • 2.1.1 Global Premature Ejaculation Treatment Revenue 2014-2025
      • 2.1.2 Global Premature Ejaculation Treatment Sales 2014-2025
    • 2.2 Premature Ejaculation Treatment Growth Rate by Regions
      • 2.2.1 Global Premature Ejaculation Treatment Sales by Regions
      • 2.2.2 Global Premature Ejaculation Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Premature Ejaculation Treatment Sales by Manufacturers
      • 3.1.1 Premature Ejaculation Treatment Sales by Manufacturers
      • 3.1.2 Premature Ejaculation Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Premature Ejaculation Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Premature Ejaculation Treatment Revenue by Manufacturers
      • 3.2.1 Premature Ejaculation Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Premature Ejaculation Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Premature Ejaculation Treatment Price by Manufacturers
    • 3.4 Premature Ejaculation Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Premature Ejaculation Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Premature Ejaculation Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Premature Ejaculation Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Premature Ejaculation Treatment Sales by Product
    • 4.2 Global Premature Ejaculation Treatment Revenue by Product
    • 4.3 Premature Ejaculation Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Premature Ejaculation Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Premature Ejaculation Treatment by Countries
      • 6.1.1 North America Premature Ejaculation Treatment Sales by Countries
      • 6.1.2 North America Premature Ejaculation Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Premature Ejaculation Treatment by Product
    • 6.3 North America Premature Ejaculation Treatment by End User

    7 Europe

    • 7.1 Europe Premature Ejaculation Treatment by Countries
      • 7.1.1 Europe Premature Ejaculation Treatment Sales by Countries
      • 7.1.2 Europe Premature Ejaculation Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Premature Ejaculation Treatment by Product
    • 7.3 Europe Premature Ejaculation Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Premature Ejaculation Treatment by Countries
      • 8.1.1 Asia Pacific Premature Ejaculation Treatment Sales by Countries
      • 8.1.2 Asia Pacific Premature Ejaculation Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Premature Ejaculation Treatment by Product
    • 8.3 Asia Pacific Premature Ejaculation Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Premature Ejaculation Treatment by Countries
      • 9.1.1 Central & South America Premature Ejaculation Treatment Sales by Countries
      • 9.1.2 Central & South America Premature Ejaculation Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Premature Ejaculation Treatment by Product
    • 9.3 Central & South America Premature Ejaculation Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Premature Ejaculation Treatment by Countries
      • 10.1.1 Middle East and Africa Premature Ejaculation Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Premature Ejaculation Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Premature Ejaculation Treatment by Product
    • 10.3 Middle East and Africa Premature Ejaculation Treatment by End User

    11 Company Profiles

    • 11.1 Absorption Pharmaceuticals
      • 11.1.1 Absorption Pharmaceuticals Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Absorption Pharmaceuticals Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Absorption Pharmaceuticals Premature Ejaculation Treatment Products Offered
      • 11.1.5 Absorption Pharmaceuticals Recent Development
    • 11.2 Bayer
      • 11.2.1 Bayer Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Bayer Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Bayer Premature Ejaculation Treatment Products Offered
      • 11.2.5 Bayer Recent Development
    • 11.3 Eli Lilly
      • 11.3.1 Eli Lilly Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Eli Lilly Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Eli Lilly Premature Ejaculation Treatment Products Offered
      • 11.3.5 Eli Lilly Recent Development
    • 11.4 Regent Pacific Group
      • 11.4.1 Regent Pacific Group Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Regent Pacific Group Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Regent Pacific Group Premature Ejaculation Treatment Products Offered
      • 11.4.5 Regent Pacific Group Recent Development
    • 11.5 Dong-A Pharmaceutical
      • 11.5.1 Dong-A Pharmaceutical Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Dong-A Pharmaceutical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Dong-A Pharmaceutical Premature Ejaculation Treatment Products Offered
      • 11.5.5 Dong-A Pharmaceutical Recent Development
    • 11.6 Emcure
      • 11.6.1 Emcure Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Emcure Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Emcure Premature Ejaculation Treatment Products Offered
      • 11.6.5 Emcure Recent Development
    • 11.7 Futura Medical
      • 11.7.1 Futura Medical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Futura Medical Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Futura Medical Premature Ejaculation Treatment Products Offered
      • 11.7.5 Futura Medical Recent Development
    • 11.8 GlaxoSmithKline
      • 11.8.1 GlaxoSmithKline Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 GlaxoSmithKline Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 GlaxoSmithKline Premature Ejaculation Treatment Products Offered
      • 11.8.5 GlaxoSmithKline Recent Development
    • 11.9 NeuroHealing Pharmaceuticals
      • 11.9.1 NeuroHealing Pharmaceuticals Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 NeuroHealing Pharmaceuticals Premature Ejaculation Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 NeuroHealing Pharmaceuticals Premature Ejaculation Treatment Products Offered
      • 11.9.5 NeuroHealing Pharmaceuticals Recent Development

    12 Future Forecast

    • 12.1 Premature Ejaculation Treatment Market Forecast by Regions
      • 12.1.1 Global Premature Ejaculation Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Premature Ejaculation Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Premature Ejaculation Treatment Market Forecast by Product
      • 12.2.1 Global Premature Ejaculation Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Premature Ejaculation Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Premature Ejaculation Treatment Market Forecast by End User
    • 12.4 North America Premature Ejaculation Treatment Forecast
    • 12.5 Europe Premature Ejaculation Treatment Forecast
    • 12.6 Asia Pacific Premature Ejaculation Treatment Forecast
    • 12.7 Central & South America Premature Ejaculation Treatment Forecast
    • 12.8 Middle East and Africa Premature Ejaculation Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Premature Ejaculation Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Premature ejaculation is one of the most common sexual dysfunctions occurring in men.
      A major reason for the market growth in the Americas is a significant rise in the number of premature ejaculation patients due to psychological factors such as strain and stress resulting from the ever-changing lifestyle.
      The global Premature Ejaculation Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Premature Ejaculation Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Premature Ejaculation Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Premature Ejaculation Treatment in these regions.
      This research report categorizes the global Premature Ejaculation Treatment market by top players/brands, region, type and end user. This report also studies the global Premature Ejaculation Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Absorption Pharmaceuticals
      Bayer
      Eli Lilly
      Regent Pacific Group
      Dong-A Pharmaceutical
      Emcure
      Futura Medical
      GlaxoSmithKline
      NeuroHealing Pharmaceuticals

      Market size by Product
      Cialis
      Viagra
      Levitra
      Market size by End User
      Supermarket
      Hospital
      Pharmacy
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Premature Ejaculation Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Premature Ejaculation Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Premature Ejaculation Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Premature Ejaculation Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Premature Ejaculation Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Premature Ejaculation Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now